Angiopoietins as prognostic biomarkers and effector molecules in severe sepsis

Critical Care Medicine

Volumn 39, Issue 9, 2011, Pages 2203-2204

  Carrol, Enitan D ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

BLOOD ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME;

EID: 80051916749     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821f02bf     Document Type: Letter

References (2)

1. Ricciuto DR, Dos Santos CC, Hawkes M, et al: Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702-710
2. Mankhambo LA, Banda DL, Jeffers G, et al: The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care 2011; 14:R91